Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard J Eigl

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Urology|January 5, 2021
Editorial CommentMaryam Soleimani, Bernhard J Eigl
The Journal of Urology|August 28, 2018
Editorial CommentBernhard J Eigl, Nawaid Usmani
European Urology|November 12, 2013
Evaluation of prostate-specific antigen response following cessation of abiraterone acetate: is there evidence for a withdrawal syndrome?Arun A Azad, Bernhard J Eigl
Advances in Therapy|February 1, 2024
The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A PodcastPeter C Black, Bernhard J Eigl
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 18, 2015
Localized prostate cancer presenting as a renal pseudo-tumourZia Poonja, Alan So, Bernhard J Eigl
The Journal of Urology|September 10, 2025
Reply: A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME StudyNawaid Usmani, Bernhard J Eigl, Arun Elangovan
Analytical and Quantitative Cytopathology and Histopathology|October 9, 2014
Composite chromophobe renal cell carcinoma with sarcomatoid differentiation containing osteosarcoma, chondrosarcoma, squamous metaplasia and associated collecting duct carcinoma: a case reportArjumand Husain, Bernhard J Eigl, Kiril Trpkov
Urology|April 6, 2016
Building the Case for Adjuvant Chemotherapy After Radical Cystectomy: Commentary on: Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder CancerLucia Nappi, Peter C Black, Bernhard J Eigl
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 15, 2013
Incremental costs of prostate cancer trials: Are clinical trials really a burden on a public payer system?Britney Jones, Rachel Syme, Misha Eliasziw, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 3, 2017
A case report of enzalutamide administration in a dialysis-dependent patient with castration-resistant prostate cancerErica S Tsang, Marie de Haan, Bernhard J Eigl
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Urology|January 5, 2021
Editorial CommentMaryam Soleimani, Bernhard J Eigl
The Journal of Urology|August 28, 2018
Editorial CommentBernhard J Eigl, Nawaid Usmani
European Urology|November 12, 2013
Evaluation of prostate-specific antigen response following cessation of abiraterone acetate: is there evidence for a withdrawal syndrome?Arun A Azad, Bernhard J Eigl
Advances in Therapy|February 1, 2024
The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A PodcastPeter C Black, Bernhard J Eigl
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 18, 2015
Localized prostate cancer presenting as a renal pseudo-tumourZia Poonja, Alan So, Bernhard J Eigl
The Journal of Urology|September 10, 2025
Reply: A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME StudyNawaid Usmani, Bernhard J Eigl, Arun Elangovan
Analytical and Quantitative Cytopathology and Histopathology|October 9, 2014
Composite chromophobe renal cell carcinoma with sarcomatoid differentiation containing osteosarcoma, chondrosarcoma, squamous metaplasia and associated collecting duct carcinoma: a case reportArjumand Husain, Bernhard J Eigl, Kiril Trpkov
Urology|April 6, 2016
Building the Case for Adjuvant Chemotherapy After Radical Cystectomy: Commentary on: Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder CancerLucia Nappi, Peter C Black, Bernhard J Eigl
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 15, 2013
Incremental costs of prostate cancer trials: Are clinical trials really a burden on a public payer system?Britney Jones, Rachel Syme, Misha Eliasziw, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 3, 2017
A case report of enzalutamide administration in a dialysis-dependent patient with castration-resistant prostate cancerErica S Tsang, Marie de Haan, Bernhard J Eigl
Pageof 7